<DOC>
	<DOCNO>NCT02959775</DOCNO>
	<brief_summary>Uptake , adherence , completion vaccination among drug user low , immune function immune response hepatitis B vaccination also suboptimal , indicate current practice hepatitis B vaccination ca n't protect drug user HBV infection . This randomized , open-label , blank-controlled trial , conduct among drug user drug rehabilitation . This study compare immunogenicity safety three intramuscular 20µg 60µg recombinant hepatitis B vaccine month 0 , 1 , 6 among drug user</brief_summary>
	<brief_title>Immunogenicity Hepatitis B Vaccination Among Drug Users</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 18 70 year enrolment current illicit drug user drug rehabilitation negative hepatitis B surface antigen ( HBsAg ) hepatitis B surface antibody ( antiHBs ) enrollment spend acute physiological detoxification phase intolerance allergy component vaccine ongoing opportunistic infection liver disease hemopathy cancer unexplained fever last week recruiting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hepatitis B vaccination</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Randomized control trial</keyword>
	<keyword>Drug abuse</keyword>
</DOC>